Clinical Trials List
2023-08-01 - 2028-03-15
Phase I
Not yet recruiting3
Recruiting1
ICD-10C56.1
Malignant neoplasm of right ovary
ICD-10C56.2
Malignant neoplasm of left ovary
ICD-10C56.9
Malignant neoplasm of unspecified ovary
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9183.0
Malignant neoplasm of ovary
-
-
Trial Applicant
-
Sponsor
-
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/05/13
Investigators and Locations
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Co-Principal Investigator
- 鄭雅敏 無
- 江佳蓉 無
- Chian-Wei Chen 無
- Keng-Fu Hsu 無
- Chien-Chung Lin 無
- Chin-Wei Kuo 無
- Cheng-Yang Chou 無
- 林語涵 無
- 蔡政軒 無
- 吳珮瑩 無
- Meng-Ru Shen 無
- 黃蘭茵 無
- Seu-Chun Yang 無
- Chun-Hui Lee 無
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Study Contacts
- -
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
Exclusion Criteria
The Estimated Number of Participants
-
Taiwan
26 participants
-
Global
1149 participants
